Patents by Inventor Diamile González Roche

Diamile González Roche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC PROTEIN COMPRISING THE RECEPTOR BINDING DOMAIN OF THE CORONA VIRUS SPIKE PROTEIN AND COMPOSITIONS COMPRISING THEM
    Publication number: 20230405106
    Abstract: The present invention provides a chimeric protein that has a modular structure and comprises a receptor binding domain (RBD) from the spike protein (S) of coronaviruses, a segment able to bind the core antigen from the Hepatitis B Virus (HBcAg), a segment including six consecutive histidine residues (HHHHHH), and two spacer segments. In this chimeric protein the aforementioned segments are arranged in a specific order, and the protein is able to form hybrid nanoparticles with HBcAg. The chimeric protein is part of vaccine compositions used for the prevention of coronavirus infections. Therefore, the invention discloses a method for the prevention of coronavirus infections, whereby a vaccine composition comprising said chimeric protein is administered.
    Type: Application
    Filed: November 3, 2021
    Publication date: December 21, 2023
    Inventors: Glay CHINEA SANTIAGO, Alejandro Miguel MARTÍN DUNN, Diamilé GONZÁLEZ ROCHE, Miladys LIMONTA FERNÁNDEZ, Enrique IGLESIAS PÉREZ, Mónica BEQUET ROMERO, Héctor SANTANA MILIAN, Gabriel J. MARQUEZ PERERA, Alexis MUSACCHIO LASA, Ania CABRALES RICO, Gerardo Enrique GUILLEN NIETO, Marta AYALA ÁVILA, Eulogio PIMENTEL VAZQUEZ, Gertrudis ROJAS DORANTES, Vivian HUERTA GALINDO
  • Immunomodulatory interleukin-2 polypeptides and methods of treating melanoma
    Patent number: 8759486
    Abstract: The present invention relates generally to polypeptides whose primary sequence has high sequence homology with human interleukin 2 (IL-2) with some punctual mutations in the sequence of native IL-2. The polypeptides of the present invention have an immunomodulatory effect on the immune system, which is selective/preferential on regulatory T cells. The present invention also relates to specific polypeptides whose amino acid sequence is disclosed herein. In another aspect the present invention relates to pharmaceutical compositions comprising as active ingredient the polypeptides disclosed. Finally, the present invention relates to the therapeutic use of the polypeptides and pharmaceutical compositions disclosed due to their immune modulating effect on diseases such as cancer and chronic infectious diseases.
    Type: Grant
    Filed: November 26, 2010
    Date of Patent: June 24, 2014
    Assignee: Centro de Inmunologia Molecular
    Inventors: Kalet León Monzón, Tania Carmenate Portilla, Karina García Martínez, Augustín Bienvendo Lage Davila, Samuel Pérez Rodríguez, Diamile González Roche, Gabriel Márquez Perera
  • IMMUNOMODULATOR POLYPEPTIDES DERIVED FROM IL-2 AND THEIR USE THEREOF IN THE THERAPEUTIC OF CANCER AND CHRONIC INFECTIONS
    Publication number: 20120315245
    Abstract: The present invention relates generally to polypeptides whose primary sequence has high sequence homology with human interleukin 2 (IL-2) with some punctual mutations in the sequence of native IL-2. The polypeptides of the present invention have an immunomodulatory effect on the immune system, which is selective/preferential on regulatory T cells. The present invention also relates to specific polypeptides whose amino acid sequence is disclosed herein. In another aspect the present invention relates to pharmaceutical compositions comprising as active ingredient the polypeptides disclosed. Finally, the present invention relates to the therapeutic use of the polypeptides and pharmaceutical compositions disclosed due to their immune modulating effect on diseases such as cancer and chronic infectious diseases.
    Type: Application
    Filed: November 26, 2010
    Publication date: December 13, 2012
    Applicant: CENTRO DE INMUNOLOGIA MOLECULAR (CIM)
    Inventors: Kalet León Monzón, Tania Carmenate Portilla, Karina García Martínez, Agustin Bienvendo Lage Davila, Samuel Pérez Rodríguez, Diamile González Roche, Gabriel Márquez Perera